Updated data disclosed from RADIANT-2 and -3 trials of everolimus in neuroendocrine tumors Feb. 2, 2011
First-line TH-302 plus gemcitabine shows promise in advanced/metastatic pancreatic cancer Feb. 1, 2011
Phase II data presented on sorafenib in GIST and esophageal/gastroesophageal junction cancer Feb. 1, 2011
Lapatinib plus capecitabine does not improve survival of patients with metastatic pancreatic cancer Jan. 31, 2011
Japanese scientists describe miRNAs in plasma and synovial fluid as biomarkers for RA and OA Jan. 31, 2011
CMC-PE hydrogel enhances nerve regeneration after experimental peripheral nerve surgery Jan. 28, 2011